These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 7528591
1. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis. Kawano Y, Takaue Y, Hirao A, Sato J, Abe T, Suzue T, Saito S, Okamoto Y, Kuroda Y. Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591 [Abstract] [Full Text] [Related]
2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394 [Abstract] [Full Text] [Related]
3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
4. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM, Gulati SC. Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [Abstract] [Full Text] [Related]
5. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells. Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V. Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323 [Abstract] [Full Text] [Related]
6. Synergism of interleukin 12, interleukin 3 and serum factor on primitive human hematopoietic progenitor cells. Hirao A, Takaue Y, Kawano Y, Sato J, Suzue T, Abe T, Saito S, Kawahito M, Okamoto Y, Makimoto A. Stem Cells; 1995 Jan; 13(1):47-53. PubMed ID: 7536512 [Abstract] [Full Text] [Related]
7. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Tanimukai S, Kimura T, Sakabe H, Ohmizono Y, Kato T, Miyazaki H, Yamagishi H, Sonoda Y. Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899 [Abstract] [Full Text] [Related]
9. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium. Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM. Stem Cells; 1997 Sep; 15(1):18-32. PubMed ID: 9007219 [Abstract] [Full Text] [Related]
15. Recombinant human mast cell growth factor supports erythroid colony formation in polycythemia vera in the presence and absence of erythropoietin and serum. Muller EW, de Wolf JT, Hendriks DW, Esselink MT, Halie MR, Vellenga E. Exp Hematol; 1993 Sep; 21(10):1353-7. PubMed ID: 7689483 [Abstract] [Full Text] [Related]
18. The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Hoffman R, Tong J, Brandt J, Traycoff C, Bruno E, McGuire BW, Gordon MS, McNiece I, Srour EF. Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331 [Abstract] [Full Text] [Related]
19. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells. Ottmann OG, Stella CC, Eder M, Reutzel P, Ströcker S, Hoelzer D, Ganser A. Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403 [Abstract] [Full Text] [Related]
20. Different responses of human marrow and circulating erythroid progenitors to stem cell factor, interleukin-3 and granulocyte/macrophage colony-stimulating factor. Kubo T, Nakahata T. Int J Hematol; 1993 Oct; 58(3):153-62. PubMed ID: 7511946 [Abstract] [Full Text] [Related] Page: [Next] [New Search]